(AGENPARL) - Roma, 12 Maggio 2023(AGENPARL) – WASHINGTON ven 12 maggio 2023 Re: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of CommentsDear Administrator Brooks-LaSure and Director Seshamani:The U.S. Chamber of Commerce (“the Chamber”) in conjunction with the Chamber’s Global Innovation Policy Center (“GIPC”) urges the Centers for Medicare and Medicaid Services (“CMS”) to re-evaluate the approach taken in CMS’s Initial Memorandum, implementing certain provisions of the Inflation Reduction Act (“IRA”). The Chamber supports appropriate efforts to ensure that every American has equitable access to life-saving medicines at fair market prices, from COVID-19 vaccines to new diagnostics and therapeutics combating some of the world’s most debilitating diseases. However, we firmly believe that both the IRA itself, and the implementation contemplated by the g
Fonte/Source: https://www.uschamber.com/health-care/u-s-chamber-comments-to-cms-on-ira-implementation-initial-memorandum-implementation-of-sections-1191-1198-of-the-social-security-act-for-initial-price-applicability-year-2026-and-solicitation-of-comments
